Back and forth action as we digest the machinations of the oil market, and some slight weakness mid-day today with news that Gilead's remdesivir flops in first trial. It's interesting to see the broken wedge acting as resistance, but the 20-moving average on the day is acting as support. Still watching to see how this plays out, with a bearish bias.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.